These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25937299)

  • 1. Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells.
    Yao W; Yue P; Zhang G; Owonikoko TK; Khuri FR; Sun SY
    Cancer Lett; 2015 Aug; 364(1):70-8. PubMed ID: 25937299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade efficacy of MEK/ERK-dependent autophagy enhances PI3K/Akt inhibitor NVP-BKM120's therapeutic effectiveness in lung cancer cells.
    Ren H; Guo H; Thakur A; Zhang S; Wang T; Liang Y; Shi P; Gao L; Liu F; Feng J; Chen T; Yang T; Shang D; Liu JJ; Xu F; Chen M
    Oncotarget; 2016 Oct; 7(41):67277-67287. PubMed ID: 27572309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer.
    Jin L; Jin MH; Nam AR; Park JE; Bang JH; Oh DY; Bang YJ
    Cancer Lett; 2017 Dec; 411():162-170. PubMed ID: 29024814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.
    Schrauwen S; Depreeuw J; Coenegrachts L; Hermans E; Lambrechts D; Amant F
    Gynecol Oncol; 2015 Jul; 138(1):165-73. PubMed ID: 25933683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities.
    Talbert EE; Yang J; Mace TA; Farren MR; Farris AB; Young GS; Elnaggar O; Che Z; Timmers CD; Rajasekera P; Maskarinec JM; Bloomston M; Bekaii-Saab T; Guttridge DC; Lesinski GB
    Mol Cancer Ther; 2017 Feb; 16(2):344-356. PubMed ID: 27811010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel hybrid of 3-benzyl coumarin seco-B-ring derivative and phenylsulfonylfuroxan induces apoptosis and autophagy in non-small-cell lung cancer.
    Dong M; Ye T; Bi Y; Wang Q; Kuerban K; Li J; Feng M; Wang K; Chen Y; Ye L
    Phytomedicine; 2019 Jan; 52():79-88. PubMed ID: 30599915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer.
    Toulany M; Iida M; Keinath S; Iyi FF; Mueck K; Fehrenbacher B; Mansour WY; Schaller M; Wheeler DL; Rodemann HP
    Oncotarget; 2016 Jul; 7(28):43746-43761. PubMed ID: 27248324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.
    Li YC; He SM; He ZX; Li M; Yang Y; Pang JX; Zhang X; Chow K; Zhou Q; Duan W; Zhou ZW; Yang T; Huang GH; Liu A; Qiu JX; Liu JP; Zhou SF
    Cancer Lett; 2014 Mar; 344(2):239-59. PubMed ID: 24280585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib.
    Park KS; Oh B; Lee MH; Nam KY; Jin HR; Yang H; Choi J; Kim SW; Lee DH
    Cancer Lett; 2016 Mar; 372(1):75-81. PubMed ID: 26723875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells.
    Ko JC; Ciou SC; Jhan JY; Cheng CM; Su YJ; Chuang SM; Lin ST; Chang CC; Lin YW
    Mol Cancer Res; 2009 Aug; 7(8):1378-89. PubMed ID: 19671683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ran GTPase induces EMT and enhances invasion in non-small cell lung cancer cells through activation of PI3K-AKT pathway.
    Ning J; Liu W; Zhang J; Lang Y; Xu S
    Oncol Res; 2013; 21(2):67-72. PubMed ID: 24406042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of hydrogen‑rich saline alone and in combination with PI3K inhibitor in non‑small cell lung cancer.
    Jiang Y; Liu G; Zhang L; Cheng S; Luo C; Liao Y; Guo S
    Mol Med Rep; 2018 Aug; 18(2):2182-2190. PubMed ID: 29901139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway.
    Sakakibara K; Tsujioka T; Kida JI; Kurozumi N; Nakahara T; Suemori SI; Kitanaka A; Arao Y; Tohyama K
    Int J Hematol; 2019 Aug; 110(2):213-227. PubMed ID: 31129802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells.
    Zhang Q; Zhu H; Xu X; Li L; Tan H; Cai X
    Biochem Biophys Res Commun; 2015 Sep; 465(1):64-70. PubMed ID: 26235873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells.
    Lee H; Kim SJ; Jung KH; Son MK; Yan HH; Hong S; Hong SS
    Oncol Rep; 2013 Aug; 30(2):863-9. PubMed ID: 23708425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer.
    Ota K; Azuma K; Kawahara A; Hattori S; Iwama E; Tanizaki J; Harada T; Matsumoto K; Takayama K; Takamori S; Kage M; Hoshino T; Nakanishi Y; Okamoto I
    Clin Cancer Res; 2015 Sep; 21(17):4014-21. PubMed ID: 26019170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jervine inhibits non-small cell lung cancer (NSCLC) progression by suppressing Hedgehog and AKT signaling via triggering autophagy-regulated apoptosis.
    Lei W; Huo Z
    Biochem Biophys Res Commun; 2020 Dec; 533(3):397-403. PubMed ID: 32972750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells.
    Lundholm L; Hååg P; Juntti T; Lewensohn R; Viktorsson K
    Int J Radiat Biol; 2014 Aug; 90(8):718-26. PubMed ID: 24646078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway.
    Chen M; Du Y; Qui M; Wang M; Chen K; Huang Z; Jiang M; Xiong F; Chen J; Zhou J; Jiang F; Yin L; Tang Y; Ye L; Zhan Z; Duan JΑ; Fu HΑ; Zhang X
    Oncol Rep; 2013 Feb; 29(2):430-6. PubMed ID: 23151908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinnamtannin D1 from Rhododendron formosanum Induces Autophagy via the Inhibition of Akt/mTOR and Activation of ERK1/2 in Non-Small-Cell Lung Carcinoma Cells.
    Way TD; Tsai SJ; Wang CM; Jhan YL; Ho CT; Chou CH
    J Agric Food Chem; 2015 Dec; 63(48):10407-17. PubMed ID: 26567590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.